Association of interleukin-6 and its-174GC promoter polymorphism with clinical and laboratory characteristics of non hepatitis C virus rheumatoid arthritis patients
Joint Authors
Hamid, Riham Muhammad Rafat
Muhammad, Sulayman Arif
Dwedar, Riham Ali
al-Khuli, Yasamin Sami
al-Jinjihi, Fatimah Talat
Source
The Egyptian Journal of Medical Human Genetics
Issue
Vol. 19, Issue 3 (31 Jul. 2018), pp.235-240, 6 p.
Publisher
Egyptian Society of Human Genetics
Publication Date
2018-07-31
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Background: Interleukin-6 is a cytokine protein, which causes inflammation, maintains immune homeostasis and shows a role in rheumatoid arthritis pathogenesis.
IL-6-174G/C promoter polymorphism may have a role in susceptibility to RA.
Aim of the work: To evaluate the clinical significance of serum levels of IL-6 and its -174G/C promoter polymorphism in RA patients in comparison with the controls.
Patients and methods: This study enrolled 25 non hepatitis C virus RA patients versus 25 age and gender matched controls.
Demographic, clinical and laboratory data were prospectively evaluated.
Serum IL-6 level and promoter (-174G/C) genotype were determined.
Results: Serum IL-6 levels was significantly higher in RA patients compared to control subjects (p = .001), especially those with CC promoter polymorphism.
There was a significant correlation between IL and 6 level and duration of morning stiffness, disease activity, hemoglobin concentration and ESR level.
15/25 patients had (-174G/G) gene promoter polymorphism, 8/25 were GC and 2/25 were CC.
All controls were GG.
There was significant association between gene polymorphism and age at disease onset (p =.0172), which was older in those with GG genotype (38.5 ± 10.25 years) than those with CC (33.5 ± 0.71 years) and younger in GC genotypes (27.9 ± 7.9 years).
None of the other clinical, laboratory or radiological parameters would predict the IL-6 promoter polymorphism.
Conclusion: Serum IL-6 levels and -174G/C promoter polymorphism were higher in RA patients than in healthy controls.
The positive correlation of IL-6 level with the DAS28 and duration of morning stiffness may confirm its’ increased involvement in the pathogenesis of RA and may point to the need for considering of anti-IL-6 agents in their management plan.
The negative correlation of IL-6 level with the hemoglobin level may confirm IL-6 play a significant role in anemia of RA.
American Psychological Association (APA)
Hamid, Riham Muhammad Rafat& Muhammad, Sulayman Arif& Dwedar, Riham Ali& al-Khuli, Yasamin Sami& al-Jinjihi, Fatimah Talat. 2018. Association of interleukin-6 and its-174GC promoter polymorphism with clinical and laboratory characteristics of non hepatitis C virus rheumatoid arthritis patients. The Egyptian Journal of Medical Human Genetics،Vol. 19, no. 3, pp.235-240.
https://search.emarefa.net/detail/BIM-836506
Modern Language Association (MLA)
Hamid, Riham Muhammad Rafat…[et al.]. Association of interleukin-6 and its-174GC promoter polymorphism with clinical and laboratory characteristics of non hepatitis C virus rheumatoid arthritis patients. The Egyptian Journal of Medical Human Genetics Vol. 19, no. 3 (Jul. 2018), pp.235-240.
https://search.emarefa.net/detail/BIM-836506
American Medical Association (AMA)
Hamid, Riham Muhammad Rafat& Muhammad, Sulayman Arif& Dwedar, Riham Ali& al-Khuli, Yasamin Sami& al-Jinjihi, Fatimah Talat. Association of interleukin-6 and its-174GC promoter polymorphism with clinical and laboratory characteristics of non hepatitis C virus rheumatoid arthritis patients. The Egyptian Journal of Medical Human Genetics. 2018. Vol. 19, no. 3, pp.235-240.
https://search.emarefa.net/detail/BIM-836506
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 240
Record ID
BIM-836506